Physician
Banker, Dipak
Banker, Dipak was paid $676K by Medicaid between Jan 2018 and May 2023, across 34 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoBANKER, DIPAK
HAVERSTRAW, NY 10927
HAVERSTRAW, NY 10927
33aNPI1851374870assigned 11/23/2005
33bProvider typePediatrics Physician
28Total paid$676K
24GClaims10,077
24DCodes billed34
24AFirst – last monthJan 2018 – May 2023
Compared with peers
Next to other Pediatrics Physician providers in New York
Rank by total paid#355 of 1,983
Median peer was paid$17K
This provider vs. median40×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 704 | $48K | |
| 2019 | 3,216 | $180K | |
| 2020 | 966 | $58K | |
| 2021 | 1,342 | $96K | |
| 2022 | 3,712 | $282K | |
| 2023 | 137 | $14K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 2,565 | 2,309 | $259K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 35% | 1,778 | 1,654 | $239K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 6.1% | 306 | 303 | $41K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.7% | 183 | 182 | $25K |
| 80050 | General health panel | 2.9% | 454 | 454 | $20K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 2.5% | 854 | 847 | $17K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.4% | 131 | 131 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.4% | 278 | 275 | $10K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.2% | 516 | 503 | $8K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 210 | 207 | $7K |
| 80061 | Lipid panel | <1% | 473 | 471 | $6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 68 | 68 | $5K |
22 more codes
| 87070 | <1% | 394 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 351 | $3K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 25 | $3K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 16 | $3K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 68 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 36 | $1K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 36 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $949.48 |
| 87634 | <1% | 13 | $912.60 | |
| 96127 | <1% | 130 | $850.23 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 66 | $547.48 |
| 80053 | Comprehensive metabolic panel | <1% | 34 | $399.16 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 13 | $384.80 |
| 36415 | Collection of venous blood by venipuncture | <1% | 352 | $373.28 |
| 90686 | <1% | 340 | $265.10 | |
| 92551 | <1% | 129 | $176.20 | |
| 87420 | <1% | 12 | $166.92 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $129.12 |
| 96160 | <1% | 71 | $89.93 | |
| 85652 | <1% | 13 | $39.00 | |
| 99173 | <1% | 120 | $3.81 | |
| 36416 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.